IdentifAI Genetics

Company Overview

Snapshot

Founded in November 2020 by Yossi Bornstein, Noam Shomron, and Oren Tadmor, IdentifAI Genetics operates with 11–50 employees. The company has raised $10.25 million across seven funding rounds from three investors. In May 2026, the BIRD Foundation provided a grant to IdentifAI Genetics, signaling continued support for its innovative prenatal testing technology.

Business overview

IdentifAI Genetics is a Health Tech & Life Sciences company specializing in noninvasive prenatal testing for the early detection of single-gene disorders. The company's core technology, the patent-pending Hoobari paradigm, utilizes algorithms developed at Tel Aviv University to analyze the entire embryonic genome from a first-trimester maternal blood test. This comprehensive analysis aims to detect single-point mutations, insertion-deletions, and structural variations to identify severe genetic disorders, serving the diagnostics and screening market within the healthcare and biotechnology sectors.

Strategic signal

In May 2026, IdentifAI Genetics received a grant from the BIRD Foundation as part of a new U.S.-Israel project. This funding validates the company's innovative approach to noninvasive prenatal testing and signals continued progress in its mission to provide solutions for safe pregnancies, reinforcing investor confidence in its technological advancements and market potential.

Company Intelligence Q&A

What is IdentifAI Genetics' primary focus?

IdentifAI Genetics is focused on developing a noninvasive prenatal test for the early detection of single-gene disorders, utilizing a first-trimester maternal blood test to analyze the entire embryonic genome.

When was IdentifAI Genetics founded and by whom?

IdentifAI Genetics was founded in November 2020 by Yossi Bornstein, Noam Shomron, and Oren Tadmor.

What significant grant did IdentifAI Genetics receive recently?

In May 2026, IdentifAI Genetics received a grant from the BIRD Foundation, supporting its innovative projects.

What is the Hoobari paradigm?

The Hoobari paradigm is IdentifAI Genetics' patent-pending proprietary methodology, developed over five years at Tel Aviv University, which uses a suite of algorithms for comprehensive genetic analysis.

What was a notable funding event for IdentifAI Genetics?

In April 2023, IdentifAI Genetics closed a post-seed funding round with eHealth Ventures as a lead investor.